Imaging and intervention for soft tissue tumours in the era of locoregional therapies and immunotherapy
- 24 May 2025
- journal article
- Published by Elsevier in Clinical Radiology
- Vol. 87, 106969
Abstract
No abstract availableKeywords
This publication has 78 references indexed in Scilit:
- The role of 18F‐FDG PET/CT in retroperitoneal sarcomas—A multicenter retrospective studyJournal of Surgical Oncology, 2021
- 18F-FDG PET/CT and MRI features of myxoid liposarcomas and intramuscular myxomasSkeletal Radiology, 2018
- Prognostic value of 18F-FDG PET/CT in patients with soft tissue sarcoma: comparisons between metabolic parametersSkeletal Radiology, 2014
- Metabolic activity measured on PET/CT correlates with clinical outcomes in patients with limb and girdle sarcomasJournal of Surgical Oncology, 2013
- Total lesion glycolysis by 18F-FDG PET/CT is a reliable predictor of prognosis in soft-tissue sarcomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 2013
- Surgical outcome of desmoid tumors: Adjuvant radiotherapy delayed the recurrence, but did not affect long‐term outcomesJournal of Surgical Oncology, 2013
- Predicting and monitoring cancer treatment response with diffusion‐weighted MRIJournal of Magnetic Resonance Imaging, 2010
- The role of core needle biopsy in the diagnosis of suspected soft tissue tumoursJournal of Surgical Oncology, 2010
- Use of positron emission tomography in localized extremity soft tissue sarcoma treated with neoadjuvant chemotherapyCancer, 2005
- Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumorsCancer, 2000